Funding Details
- Awarder
- PlugAndPlayTechCenter
- Date Award
- May 15, 2024
- Funding URL
- View Funding Page
Company Info
- Company Description
- Neurotrack works with re/insurers, pharma, and healthcare providers to develop new solutions to assess, monitor and reduce the risk of cognitive decline and Alzheimer's disease (AD). Neurotrack's core technology includes a suite of complementary solutions:
-- Digital Assessment Platform: Neurotrack’s digital assessment platform uses advanced computer vision technology to create consistent and sensitive measures of cognitive health. The assessments represent a novel digital biomarker that can quantify performance across the major domains of cognition.
-- Cognitive Health Program: The Cognitive Health Program is a digital, multi-domain lifestyle intervention that is designed to reduce risk for developing cognitive decline. This program is based on the landmark FINGER trial, which demonstrated that a multi-domain lifestyle intervention can reduce Alzheimer's disease risk and slow cognitive decline.
Links